Clean Science & Technology’s (CLEAN) 4QFY22 EBITDA came in ~14% ahead of our estimate mainly on account of strong revenue growth across geographies, except China.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.